Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors
NCT01334073
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Malignant Advanced Solid Tumors
Carcinoma, Renal Cell
Interventions
DRUG:
Axitinib plus everolimus
Sponsor
University Hospital, Bordeaux